partial thromboplastin and thrombin times. Improvement in plasma recalcification and partial thromboplastin times was probably related to the elevation of low factor V and X levels and possibly to ...

For people with the bleeding disorder hemophilia, life can seem like one continuous state of alertness. If they accidentally ...

Four years ago, protein drug developer Zymogenetics in Seattle began developing a recombinant version of the blood-clotting protein thrombin. On 17 January, it received US marketing approval for ...